# Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

> **NCT05496998** · NA · RECRUITING · sponsor: **Medtronic Cardiovascular** · enrollment: 400 (estimated)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DEVICE:** Medtronic Intrepid™ TMVR TF System

## Key facts

- **NCT ID:** NCT05496998
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-07
- **Primary completion:** 2029-08
- **Final completion:** 2038-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05496998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05496998, "Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05496998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*